Inhibition of native TRPC6 channel activity by phosphatidylinositol 4,5-bisphosphate in mesenteric artery myocytes by Albert, Anthony P et al.
J Physiol 586.13 (2008) pp 3087–3095 3087
RAPID REPORT
Inhibition of native TRPC6 channel activity by
phosphatidylinositol 4,5-bisphosphate in mesenteric
artery myocytes
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The present work investigates the effect of phosphatidylinositol-4,5-bisphosphate (PIP2)
on native TRPC6 channel activity in freshly dispersed rabbit mesenteric artery myocytes
using patch clamp recording and co-immunoprecipitation methods. Inclusion of 100μM
diC8-PIP2 in the patch pipette and bathing solutions, respectively, inhibited angiotensinII
(AngII)-evoked whole-cell cation currents and TRPC6 channel activity by over 90%. In
inside-out patches diC8-PIP2 also inhibited TRPC6 activity induced by the diacylglycerol
analogue 1-oleoyl-2-acetyl-sn-glycerol (OAG) with an IC50 of 7.6μM. Anti-PIP2 antibodies
potentiated AngII- and OAG-evoked TRPC6 activity by about 2-fold. Depleters of tissue PIP2
wortmannin and LY294002 stimulated TRPC6 activity, as did the polycation PIP2 scavenger
poly-L-lysine. Wortmannin reduced AngII-evoked TRPC6 activity by over 75% but increased
OAG-induced TRPC6 activity by over 50-fold. Co-immunoprecipitation studies demonstrated
associationbetweenPIP2 andTRPC6proteinsintissuelysates.Pre-treatmentwithAngII,OAG
and wortmannin reduced TRPC6 association with PIP2. These results provide for the ﬁrst time
compelling evidence that constitutively produced PIP2 exerts a powerful inhibitory action on
native TRPC6 channels.
(Received 10 March 2008; accepted after revision 1 May 2008; ﬁrst published online 8 May 2008)
Corresponding author A. Albert: Ion Channels & Cell Signalling Research Centre, Division of Basic Medical Sciences,
St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK. Email: aalbert@sgul.ac.uk
Members of the canonical class of transient receptor
potential (TRPC) non-selective Ca2+-permeable cation
channels are present in many types of smooth muscle
(see Large, 2002; Beech et al. 2004; Albert & Large, 2006;
Albert et al. 2007). These channels have been implicated
in many physiological responses in vascular tissue such as
depolarization, contraction, gene expression, cell growth
and proliferation. Classically TRPC channels are often
described as receptor-operated (ROCs) or store-operated
channels (SOCs) with ROCs being stimulated by
G-protein-coupled receptors linked to phospholipase C
(PLC) and SOCs stimulated by depletion of internal
Ca2+ stores. However, little is known about the precise
mechanisms by which TRPC-mediated ROCs and SOCs
are gated.
In rabbit vascular myocytes there are several
TRPC ROC isoforms where one product of
phosphatidylinositol-4,5-bisphosphate hydrolysis (PIP2)
byPLC,diacylglycerol(DAG),initiateschannelopeningby
a protein kinase C (PKC)-independent mechanism. DAG
stimulates TRPC6 activity in portal vein and mesenteric
artery, TRPC3 in ear artery and TRPC3/TRPC7 in
coronary artery myocytes in this manner although
it is not known how DAG produces channel gating
(Helliwell & Large, 1997; Inoue et al. 2001; Albert et al.
2005, 2006; Saleh et al. 2006; Peppiatt-Wildman et al.
2007). Moreover the other product of PIP2 hydrolysis,
inositol 1,4,5-trisphosphate (IP3), markedly potentiates
TRPC6-like and TRPC3/TRPC7 channel opening in,
respectively, portal vein and coronary artery myocytes
(Albert & Large, 2003; Peppiatt-Wildman et al. 2007). In
the present work we have investigated the role of PIP2
in regulating native TRPC6 activity since PIP2 is the
precursor of both DAG and IP3 and has been shown to
independently regulate the function of many ion channel
proteins including members of the TRP superfamily
(see Suh & Hille, 2005; Rohacs, 2007; Voets & Nilius,
2007). Recently it was demonstrated that PIP2 increased
expressed TRPC3, -C6 and -C7 activity in HEK293
cells (Lemonnier et al. 2008) and it was suggested that
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phosphoinositides, including PIP2, mediate increases in
TRPC6 activity due to disruption of calmodulin (CaM)
binding to fusion proteins containing the C-termini of
TRPC6 (Kwon et al. 2007). In contrast, PIP2 inhibited
receptor-operated TRPC4α activity in HEK293 cells
(Otsuguro et al. 2008). These results illustrate complex
e f f e c t so fP I P 2 on expressed TRPC channels but to date
there have been no studies on the effect of PIP2 on
native TRPC channels. Therefore, in the present study,
we investigated the effect of PIP2 on TRPC6 channels in
freshlydispersedrabbitmesentericarterymyocytes.These
novel results show that PIP2 exerts a powerful inhibitory
brake on agonist-evoked TRPC6 activity. Moreover,
simultaneous depletion of PIP2 and production of DAG
are necessary for optimal channel activation.
Methods
Cell isolation
New Zealand White rabbits (2–3kg) were killed using
i.v. sodium pentobarbitone (120mgkg−1, in accordance
with the UK Animals (Scientiﬁc Procedures) Act, 1986).
1st to 5th order mesenteric arteries were dissected free
from fat and connective tissue and enzymatically digested
into single myocytes using methods previously described
(Saleh et al. 2006).
Electrophysiology
Whole-cell and single cation currents were recorded
with an AXOpatch 200B patch-clamp ampliﬁer (Axon
Instruments, USA) at room temperature (20–23◦C)
using whole-cell recording, cell-attached, inside-out and
outside-outpatchconﬁgurationsanddataacquisitionand
analysis protocols as previously described (Saleh et al.
2006). Brieﬂy, single channel current amplitudes were
calculated from idealized traces of at least 60s in duration
usingthe50%thresholdmethodwitheventslastingforless
than0.664ms (2× rise time for a 1kHz, −3db, low-pass
ﬁlter) being excluded from analysis. Figure preparation
was carried out using MicroCal Origin software 6.0
(MicroCal Software Inc., MA, USA) where inward single





T where n is the number of channels in the
patch, On is the time spent at each open level and T is the
total recording time.
Immunoprecipitation and Western blotting
Dissected tissues were either ﬂash frozen and stored at
−80◦C for subsequent use or immediately placed into
10mgml−1 RIPA lysis buffer (Santa Cruz Biotechnology)
supplemented with protease inhibitors and then homo-
genized on ice by sonication for at least 3h. The
total cell lysate (TCL) was collected by centrifugation
at 10g for 10min at 4◦C and then protein content
was quantiﬁed using the Bio-Rad protein dye reagent
(Bradford method). TCL was pre-cleared using A/G
agarose beads (Santa Cruz Biotechnology) and immuno-
precipitated overnight at 4◦C using the appropriate
antibody and A/G agarose bead conjugate. Alternatively,
the immunoprecipitation protocol was carried out using
the Upstate Catch and Release kit (Millipore), where spin
columns were loaded with 500μg of cell lysates, 4μg
of antibody and immunoprecipitated for 2h at room
temperature.
Protein samples were eluted with Laemmli sample
buffer and incubated at 95◦C for 2min. One-dimensional
protein gel electrophoresis was performed in 4–12%
Bis–Tris gels in a Novex mini-gel system (Invitrogen)
with 20μg of total protein loaded in each lane. Separated
proteins were electrophoretically transferred onto poly-
vinylidene diﬂuoride membranes in a Biorad trans-blot
SD semi-dry transfer cell or using the iBlot apparatus
(Invitrogen). Blots were incubated for 1–4h with 5%
(weight/volume) non-fat milk in phosphate-buffered
saline (PBS) containing 0.1% Tween20 (PBST) to block
non-speciﬁc protein binding. Membranes were then
incubated with appropriate primary antibody overnight
at 4◦C (where possible alternative antibodies raised
against different epitopes were used for immuno-
precipitation and Western blot analysis). Following anti-
body removal blots were washed for 2h with milk–PBST.
Blots were subsequently incubated with horseradish
peroxidase-conjugated goat anti-rabbit (Sigma) or sheep
anti-goat (Santa Cruz Biotechnology) IgG secondary
antibody diluted 1:1000–1:5000 in milk–PBST, washed
3timesinPBST,andtreatedwithECLchemiluminescence
reagents (Pierce) for 1min and exposed to photographic
ﬁlms. In loading control experiment anti-β-actin anti-
bodies (mouse monoclonal, Sigma, UK) were also added
to the immunoprecipitate and immunoblot procedures
to show that expression levels of β-actin did not change
during the experimental conditions. Moreover, immuno-
blot control data showed that anti-PIP2 and anti-TRPC6
antibodies did not recognize β-actin following immuno-
precipitation with only anti-β-actin antibodies. Data
shown represent n values of at least three separate
experiments.
Anti-TRPC6 and anti-PIP2 antibodies
Polyclonal TRPC6 antibody generated in rabbits against
an intracellular epitope was purchased from Alomone
Laboratories (Jerusalem, Israel) and the selectivity and
negligible cross-reactivity of this antibody for its target
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protein has been previously conﬁrmed (Liu et al. 2005;
Sours et al. 2006). An alternative polyclonal antibody for
TRPC6 generated in goats against a different intracellular
epitope was purchased from Santa Cruz Biotechnology
and the speciﬁcity of this antibody has also been
previouslyconﬁrmed(Liuetal.2005).Mousemonoclonal
PIP2 antibody generated against liposomes of human
origin constituted with the phospholipid was purchased
from Assay Designs (USA). This anti-PIP2 antibody has
previously been used in electrophysiological (Liou et al.





The bathing solution used to measure whole-cell cation
currents was K+ free and contained (mm): NaCl (126),
CaCl2(1.5),Hepes(10),glucose(11),DIDS(0.1),niﬂumic
acid (0.1) and nicardipine (0.005), pH to 7.2 with
NaOH. In cell-attached patch experiments the membrane
potential was set to approximately 0mV by perfusing
cells in a KCl external solution containing (mm): KCl
(126), CaCl2 (1.5), Hepes (10) and glucose (11), pH to 7.2
with 10m KOH. Nicardipine (5μm) was also included to
prevent smooth muscle cell contraction by blocking Ca2+
entry through voltage-dependent Ca2+ channels.
The patch pipette solution used to measure whole-cell
cation currents (intracellular solution) was also K+ free
and contained (mm): CsCl (18), caesium aspartate (108),
MgCl2 (1.2), Hepes (10), glucose (11), BAPTA (10),
CaCl2(4.8,freeinternalCa2+concentrationapproximately
100nm as calculated using EQCAL software), Na2ATP
(1) and NaGTP (0.2), pH7.2 with Tris. The patch
pipettesolutionusedforbothcell-attachedandinside-out
patch recording (extracellular solution) was K+ free and
contained (mmoll−1): NaCl (126), CaCl2 (1.5), Hepes
(10), glucose (11), TEA (10), 4-AP (5), iberiotoxin
(0.0002), DIDS (0.1), niﬂumic acid (0.1) and nicardipine
(0.005), pH to 7.2 with NaOH. The composition of
the bathing solution used in inside-out experiments
(intracellular solution) was the same as the patch pipette
solution used for whole-cell recording except that 1mm
BAPTA and 0.48mm CaCl2 were included (free internal
Ca2+ concentration approximately 100nm). Under these
conditions VDCCs, K+ currents, swell-activated Cl−
currents and Ca2+-activated conductances are abolished
and non-selective cation currents could be recorded in
isolation.
DiC8-PIP2 was purchased from Cayman chemicals
(UK). All other drugs were purchased from Calbiochem
(UK), Sigma (UK) or Tocris (UK) and agents were
dissolvedindistilledH2OorDMSO(0.1%).DMSOalone
had no effect on TRPC6 channel activity. The values are
the mean of n cells ±s.e.m. Statistical analysis was carried
out using paired (comparing effects of agents on the same
cell) or unpaired (comparing effects of agents between
cells) Students’ t test with the level of signiﬁcance set at
P<0.05.
Results
DiC8-PIP2 inhibits native TRPC6 channel activity
in rabbit mesenteric artery myocytes
In initial experiments we investigated the effect of
including 100μm diC8-PIP2, a water-soluble form of
PIP2, in the patch pipette solution on angiotensinII
(AngII)-inducedwhole-cellcationcurrentsinmesenteric
arterymyocytes.Intheseexperimentsweused1nmAngII
since previous work showed that 1nm AngII activated
native TRPC6 channels (Saleh et al. 2006). Figure1Aa
and b shows that 100μm diC8-PIP2 reduced the mean
peak amplitude of whole-cell cation currents induced
by 1 nm AngII from −26±8pA(n=7) to −2±0.5pA
(n=7,P<0.01)at−50mV.Figure1Ac alsoshowsthatthe
AngII-evoked mean current–voltage (I–V) relationship
was inhibited by 100μm diC8-PIP2 at all membrane
potentials between −100mV and +90mV.
To obtain precise information on the effect of
PIP2 on TRPC6 channel activity and to exclude the
possibility of observing actions of PIP2 on multiple
cation conductances we studied the effect of PIP2 on
TRPC6 activity at the single channel level. Figure1Ba
shows that bath application of 1nm AngII evoked
channel activity in a cell-attached patch, which had
similar unitary properties to TRPC6 channels previously
described (Saleh et al. 2006), and was maintained
following excision of the patch into the inside-out
conﬁguration for up to 30min. Figure1Ba shows that
bath application of 100μm diC8-PIP2 to the cytosolic
surface of the inside-out patch reversibly inhibited the
mean open probability (NPo) of AngII-evoked TRPC6
activity from 3.81±0.84 to 0.43±0.21 (n=6, P<0.05)
at −50mV. Previously it has been shown that DAG
activates TRPC6 channels in mesenteric artery myocytes
byaPKC-independentmechanism.Figure1Bb showsthat
bath application of 10μm 1-oleoyl-2-acetyl-sn-glycerol
(OAG), a cell-permeable DAG analogue, to an inside-out
patchalsoinducedchannelactivitywithTRPC6properties
(Saleh et al. 2006). Moreover, Fig.1Bb shows that bath
applicationof100μmdiC8-PIP2reversiblyinhibitedmean
NPo of OAG-induced TRPC6 activity from 1.49±0.03
to 0.09±0.03 (n=6, P<0.01) at −50mV diC8-PIP2
at 100μm also inhibited OAG-evoked TRPC6 activity
by 89 ±5% (n=3, data not shown) in the presence of
the PKC inhibitor chelerythrine (3μm) indicating that
PIP2-mediated inhibition of TRPC6 did not involve PKC
(see Saleh et al. 2006). Figure1C shows a dose–response
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curve of diC8-PIP2 on TRPC6 activity induced by 10μm
OAGininside-outpatchesat−50mVwith50%inhibition
(IC50)p r o d u c e db y7 . 6μm diC8-PIP2.
Endogenous PIP2 inhibits TRPC6 activity
The above data clearly demonstrate that diC8-PIP2 has
a profound inhibitory action on TRPC6 activity in
mesenteric artery myocytes. Therefore we investigated
the role of endogenous PIP2 on TRPC6 activity by
studying the effect of anti-PIP2 antibodies on TRPC6
activity induced by AngII and OAG in inside-out
patches.
Figure2Aa shows that bath application of anti-PIP2
antibodies at 1:200 to an inside-out patch, in
which TRPC6 channels were activated initially in the
cell-attached mode by 1nm AngII (i.e. similar to Fig.1B),
increased TRPC6 activity (about 2-fold) but after 2min
there was a marked decrease in NPo (Fig.2Aa and B).
Figure2Ab illustrates that bath application of anti-PIP2
Figure 1. DiC8-PIP2 inhibits Ang II-evoked whole-cell cation currents and single TRPC6 channel activity
in rabbit mesenteric artery myocytes
Aa and b, inclusion of 100 μM diC8-PIP2 in the patch pipette solution inhibits whole-cell cation currents evoked by
1n M Ang II. Ac, mean I–V relationship showing diC8-PIP2 inhibits Ang II-evoked cation currents at all potentials
tested (n = at least 4 per point). Ba, 100 μM diC8-PIP2 inhibited TRPC activity in an inside-out patch which was
initially activated by 1 nM Ang II in a cell-attached patch (i/o, inside-out patch). Bb, 100 μM diC8-PIP2 inhibited
TRPC activity induced by 10 μM OAG in an inside-out patch. C, inhibitory action of diC8-PIP2 on OAG-evoked
TRPC6 activity in inside-out patches had an IC50 value of 7.6 μM (n = at least 4 per point).
antibodies at 1:200 dilution also increased OAG-evoked
TRPC6 activity in inside-out patches by approximately
2-foldbutunlikeAngIItherewasnosubsequentinhibition
of channel activity in the continued presence of the
antibody (Fig.2Ab and B).
Agents that deplete PIP2 levels activate TRPC6 activity
in un-stimulated mesenteric artery myocytes
These present results indicate that endogenous PIP2
exerts a powerful inhibitory action of TRPC6 channels.
In addition, previous work using an inhibitor of DAG
lipase showed that these channels are also activated
by constitutive DAG production (Saleh et al. 2006).
We therefore investigated the effect of wortmannin and
LY294002 on cell-attached patches from unstimulated
myocytes since at high concentrations these agents are
known to inhibit phosphoinositol (PI)-4-kinases leading
to a reduction in the generation of PIP2 and consequently
a depletion of PIP2 levels (Suh & Hille, 2005).
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Figure3Aa shows that bath application of 20μm
wortmannin evoked channel activity with a mean peak
NPo value of 1.79±0.42 (n=14) at −50mV. Amplitude
histograms of wortmannin-induced channel currents
could be ﬁtted by the sum of three Gaussian curves with
three sub-conductance states of 15pS, 28pS and 44pS
which all had a reversal potential (Er)o fa b o u t0 m V
(Fig.3Ab and c). These characteristics are identical to
AngII- and OAG-evoked TRPC6 channel currents (see
Saleh et al. 2006). Figure3Ba, b and c shows that bath
application of 100μm LY294002 evoked TRPC6 activity
with a mean peak NPo value of 0.37±0.01 (n=60) at
−50mV. TRPC6 activity induced by wortmannin and
LY294002 was transient with no activity detected after
5min in the presence of these agents. At concentrations
that do not inhibit PI-4 kinases, wortmannin (50nm) and
LY294002 (10μm) had no effect on TRPC6 activity.
Figure3Ca shows that bath application of the poly-
cation PIP2 scavenger poly-l-lysine (50μgml −1)t oa n
inside-out patch activated channel activity with a mean
peak NPo value of 1.52±0.34 (n=10) at −50mV.
These poly-l-lysine-evoked channel currents had similar
conductances/Er values to those induced by wortmannin
and LY294002 (Fig.3Cb and c).
Depletion of PIP2 levels reduces Ang II- but increases
OAG-evoked TRPC6 activity
These results show that endogenous and exogenous PIP2
inhibitsAngII-andOAG-evokedTRPC6activityandthat
PIP2alsopreventschannelopeninginducedbyconstitutive
Figure 2. Anti-PIP2 antibody potentiates TRPC6 channel activity
Aa, 1 : 200 dilution of anti-PIP2 antibodies transiently increased TRPC6 activity in an inside-out patch which was
induced by 1 nM Ang II in cell-attached mode. Subsequently the Ang II-evoked response was inhibited in the
presence of the anti-PIP2 antibody. Ab, 1 : 200 dilution of anti-PIP2 antibodies produced a sustained increase of
OAG-evoked TRPC6 activity in an inside-out patch. B, mean data of effect of anti-PIP2 antibodies on Ang II- and
OAG-induced TRPC6 activity (n = 6 for all conditions, ∗∗P < 0.01).
generationofDAG.However,stimulationofAT1 receptors
by AngII involves PLC-mediated PIP2 hydrolysis leading
to DAG production and TRPC6 activity (Saleh et al.




Figure4Aa, b and C shows that 15min preincubation
with 20μm wortmannin reduced AngII-evoked TRPC6
activity by about 75%. In contrast, Fig.4Ba, b and C
shows that 10μm OAG produced little stimulation of
TRPC6 activity in control cell-attached patches. However,
following pre-treatment with 20μm wortmannin for
15min OAG-evoked TRPC activity was markedly
increased by over 50-fold (P<0.001).
Association of PIP2 with TRPC6 proteins is reduced
by pre-treatment with wortmannin and OAG
These data suggest that PIP2 inhibits TRPC6 activity
stimulated by AngII and OAG but also that PIP2 acts as
a precursor for endogenous DAG production by AngII.
In contrast, sustained TRPC6 activation by OAG does
not require PIP2 as a DAG precursor. We investigated
whether there is evidence for close association between
PIP2 and TRPC6 proteins using co-immunoprecipation
andWesternblottingandwhetherassociationisalteredin
the presence of AngII, OAG and wortmannin.
Figure4Daillustratesthattissuelysatesfrommesenteric
artery immunoprecipitated with anti-PIP2 and then
blotted with anti-TRPC6 antibodies displayed a band of
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∼110kDa which is the expected molecular weight for
TRPC6 proteins. Complementary studies showed that
association between TRPC6 and PIP2 could be obtained
usinganti-TRPC6forimmunoprecipitationandanti-PIP2
for blotting (data not shown). Figure4Da also shows that
incubation with 1nm AngII, 10μm OAG and 20μm
wortmannin for 15min before tissue lysis all reduced
the association of TRPC6 proteins with PIP2.M o r e o v e r ,
Fig.4Db shows that wortmannin reduced, whereas AngII
andOAGhadlittleeffect,ontotaltissuePIP2levelsdetected
with Western blotting. Figure4Da and c illustrates that
wortmannin,AngIIandOAGhadnoeffectonexpression
levels of β-actin or TRPC6.
Discussion
The present data clearly show that in addition to acting
as a precursor of DAG production endogenous PIP2
also inhibits native TRPC6 channel activity in rabbit
Figure 3. Agents that deplete PIP2 evoke TRPC6 channel activity
A and B, respectively, 20 μM wortmannin and 100 μM LY294002 transiently activated channel activity in
cell-attached patches (a) which had similar amplitude histograms (b) and unitary conductances and Er values
(c). C,5 0μgm l −1 poly-L-lysine activated channel currents in an inside-out patch (a) which had a similar properties
to those evoked by wortmannin and LY294002 (b and c).
mesenteric artery myocytes. Morever, PIP2 imposes a
brake on TRPC6 activation by both AngII and DAG.
This latter result represents a novel physiological role for
this important phospholipid in vascular smooth muscle
excitation and may suggest that DAG activates TRPC6
channels by reducing this inhibitory action of PIP2 on
channel proteins.
DiC8-PIP2 inhibited AngII-evoked whole-cell curents




(Zhang et al. 2003) and to fusion proteins composed of
TRPC6C-termini(Kwonetal.2007).Anti-PIP2antibodies
initially increased TRPC6 activity induced by AngII,
which is likely to be caused by removal of an inhibitory
action of endogenous PIP2. In the continued presence of
anti-PIP2 antibodies, AngII-induced TRPC6 activity was
greatly reduced, which presumably reﬂects a reduction in
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PIP2requiredtoproduceendogenousPLC-mediatedDAG
production and TRPC6 opening. This is consistent with
AngII-evoked TRPC6 activity being almost completely
blocked by U73122, a PLC inhibitor, indicating a pivotal
role for PLC in the transduction pathway (Saleh et al.
2006). Predictably, anti-PIP2 antibodies only potentiated
OAG-evoked TRPC6 activity because OAG acts down-
streamofPLC-mediatedPIP2hydrolysis.Ithasbeenshown
that PIP2 binds to expressed TRPC6 proteins in HEK293
cells (Tseng et al. 2004) and to fusion proteins composed
of TRPC6 C-termini (Kwon et al. 2007), and the present
co-immunoprecipitation work also shows that endo-
genous PIP2 associates with native TRPC6 proteins in
Figure 4. Wortmannin-induced depletion of PIP2 decreases Ang II-evoked and increases OAG-induced
TRPC6 activity in cell-attached patches
A shows that Ang II-evoked TRPC6 activity (a) is decreased after pre-treatment with wortmannin (b). B illustrates
that OAG-induced TRPC6 activity (a) is markedly increased following pre-treatment with wortmannin (b). C, mean
data showing effect of wortmannin on Ang II- and OAG-induced TRPC6 activity (∗∗∗P < 0.001). Da shows a
co-immunoprecitation experiment in which mesenteric artery tissue lysates were immunoprecipitated (IP) with an
anti-PIP2 antibody and then Western blotted (WB) with an anti-TRPC6 antibody. In control conditions a band of
∼110 kDa was observed which was absent after pre-treatment of the tissue with 20 μM wortmannin, 1 nM Ang II
and 10 μM OAG for 15 min. Note that similar results were obtained with both anti-TRPC6 antibodies (Alomone and
Santa Cruz). Db, immunoblot with anti-PIP2 antibody showing reduction of total tissue PIP2 levels after incubation
with 20 μM wortmannin for 15 min. Pre-treatment with 1 nM Ang II and 10 μM OAG for 15 min had little effect
on total tissue PIP2 levels. Dc, immunoblot with anti-TRPC6 antibody showing pre-treatment of tissue with 20 μM
wortmannin, 1 nM Ang II and 10 μM OAG and for 15 min had no effect on expression of TRPC6 protein. Note that
all immunoprecipiation and immunoblot experiments were from at least n = 3.
unstimulated tissue lysates. The mechanism(s) by which
anti-PIP2 antibodies prevent the inhibitory action of PIP2
is unknown. However, it is likely that recycling of PIP2
means that this phospholipid can be free or bound to
TRPC6. Therefore, a simple explanation is that the free
PIP2–anti-PIP2 antibody complex binds less readily to
TRPC6 and is less readily hydrolysed by PLC.
Furtherevidenceforaninhibitoryactionofendogenous
PIP2 on TRPC6 activity is that wortmannin, LY294002
and poly-l-lysine, which all deplete PIP2 levels, produced
activation of TRPC6 channels in unstimulated myocytes.
In mesenteric artery myocytes there is likely to be
constitutive production of DAG because an inhibitor of
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DAG lipase, which is the main pathway for metabolism of
DAG in smooth muscle (Severson & Hee-Cheong, 1989),
activates TRPC6 channels (Saleh et al. 2006). It is likely
that wortmannin and LY294002 evoked TRPC6 activity
by inhibiting PI-4-kinases which produces a reduction
in PIP2 synthesis (Suh & Hille, 2005) due to recycling
of this phospholipid. Thus leading to removal of its
inhibitory action, and channel opening by constitutive
generation of DAG. The transient nature of the excitatory
effects of wortmannin and LY294002 is also consistent
with the idea that opening of TRPC6 channels requires
PIP2-mediated DAG production. Therefore, depletion of
PIP2 will lead eventually to reduced DAG production
and channel activation. Indeed, co-immunoprecipitation
studies showed that wortmannin reduced both the
association of PIP2 with TRPC6 proteins and PIP2
levels in unstimulated tissue lysates. Wortmannin also
produced transient TRPC6 activity and greatly reduced
noradrenaline-evoked TRPC6 currents in portal vein
indicating that PIP2 may have a similar action on TRPC6
in this preparation (Aromolaran et al. 2000; Inoue et al.
2001).
As expected, wortmannin reduced AngII-evoked
TRPC6 activity, which correlated with depletion of tissue
PIP2 levels and decreased association between PIP2 and
TRPC6 proteins demonstrated by Western blotting and
co-immunoprecipitation. A notable result was that in the
presence of wortmannin, OAG-evoked TRPC6 activity
in cell-attached patches was enhanced by about 50-fold,
whereas OAG-induced TRPC6 activity in inside-out
patches was only increased 2-fold by an anti-PIP2 anti-
body. These differences in potentiation of TRPC6 activity
by depletion of PIP2 probably relate to the relative activity
of OAG alone in the different patch conﬁgurations with
OAG evoking much larger activity in inside-out than
in cell-attached patches (see Figs1Ba and 4Ba). These
differences in stimulation of TRPC6 by OAG may suggest
that in inside-out patches OAG is more effective at
removing the inhibitory action of PIP2 and/or there are
lowerlevelsofPIP 2 inapatchfollowingexcision.However,
whatisconclusivefromthesedataisthatthereareopposing
inhibitory effects of PIP2 and excitatory DAG actions on
TRPC6 proteins.
An intriguing observation was that OAG reduced
association between PIP2 and TRPC6 proteins without
reducing tissue PIP2 levels. We are cautious in concluding
any mechanism from these results although it is tempting
to speculate that a simple model of mutual antagonism
between DAG and PIP2, perhaps at a similar binding
site(s), may underlie the mechanism by which TRPC6
proteins are activated by DAG via a PKC-independent
mechanism. However, it is also possible that DAG may
partially activate TRPC6, which in turn allows entry
of Ca2+ ions leading to subsequent activation of PLC
and PIP2 hydrolysis. Considerably more work including
identiﬁcationofmutualDAGandPIP2bindingsiteswithin
TRPC6proteinsandinvestigationoftheroleofPLCwillbe
required to prove these possible activation mechanisms of
TRPC6. Nevertheless, our data suggest that simultaneous
depletion of PIP2 and production of DAG is necessary
for activation of native TRPC6 activation as previously
proposed for TRP channels in Drosophila (Estacion et al.
2001; Hardie, 2003).
It is not clear why our data showing that PIP2 has an
inhibitory effect on native TRPC6 channels is opposite to
thefacilitatoryresponseseeninexpressedTRPC6channels
(Kwon et al. 2007; Lemonnier et al. 2008) although it
should be noted that the work of Kwon et al. mainly
focused on the role of PIP3 in regulating TRPC6 activity.
Lemonnieretal.(2008)mayhaveobservedpotentiationof
TRPC6 activity by PIP2 through the phospholipid acting
as a substrate for generation of DAG, particularly if there
wasanexcessofexpressedTRPC6proteinscomparedwith
endogenous PIP2 levels in HEK293 cells. However, our
present results may explain why pre-treatment with
low doses of carbachol, which are likely to lower PIP2
levels, enhanced OAG-evoked TRPC activity expressed in
HEK293 cells (Estacion et al. 2004).
In conclusion, endogenous PIP2 imposes an inhibitory
action on native TRPC6 channels in mesenteric artery
myocytes. Removal of this tonic inhibitory effect leads
to TRPC6 channel activation indicating that PIP2 has
a dual role of being a precursor for DAG production
for channel activation and a direct inhibitor of the ion
channel. This may represent an important novel physio-
logicalactivationmechanismofnativeTRPC6channelsin
vascular myocytes and may also be a common activation
mechanism of other TRPC proteins stimulated by DAG
via a PKC-independent pathway.
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